RHO-CURE – Development of pharmacological treatment options to halt retinal degeneration caused by dominant rhodopsin mutations

DRUGSFORD-bis – Towards a clinical trial for hereditary retinal degeneration

DRUGSFORD-bis: Towards a clinical trial for hereditary retinal degeneration

RD-CURE – Bringing Gene Supplementation Therapy for Inherited PDE6A- and CNGA3-associated Retinopathies into Clinical Practice

Calcium dynamics in degenerating cone photoreceptors

HDAC inhibition protects degenerating cone photoreceptors in vivo

PersonalMed – Personalized medicine: PARP inhibition as a means to save photoreceptors in Pde6a mutant mouse retina, genotype matched to human Retinitis Pigmentosa patients

RD-CURE – Bringing Gene Supplementation Therapy for PDE6 Associated Retinopathies into Clinical Practice

ARI-YI Grant – Developing HDAC inhibitors to treat inherited photoreceptor degeneration

DRUGSFORD – Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration